Stephanie Gentile

Cooley advised H1, a global healthcare data technology company, on its acquisition of Ribbon Health.

Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).

Cooley represented Topology Ventures, a frontier tech venture firm with an engineering-first approach, in connection with the launch and closing of its oversubscribed $75 million inaugural fund that was backed by endowments, fund of funds and leaders in the artificial intelligence space.

Cooley advised Brigit, a financial health technology company, on its definitive agreement to be acquired by Upbound Group (Nasdaq: UPBD), a technology- and data-driven leader in accessible and inclusive financial products that address the evolving needs and aspirations of underserved consumers, for total consideration of up to $460 million.

Cooley advised Frame AI, an artificial intelligence-powered platform, on its sale to HubSpot, the leading customer platform for scaling businesses.